Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 36983

Berlin, NJ 08009


Study Summary:

A PHASE Ib, RANDOMIZED, BLINDED, PLACEBOCONTROLLED, MULTIPLE ASCENDING−DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUBCUTANEOUS BFKB8488A IN PATIENTS WITH TYPE 2 DIABETES MELLITUS


Qualified Participants Must:

• Be between 18 and 75 years of age
• Have a BMI between 27 and 40
• Have Type II diabetes for at least 6 months
• Hba1c between 6.8% and 9.0%
• Type II diabetes can be controlled by diet or medication


Qualified Participants May Receive:

Up to $1,700


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.